With the first identification of CYP24A1 in breast cancer as a candidate oncogene [12], an increased or decreased CYP24A1 expression has been identified distinctively in various cancers such as prostate, endometrial, and lung [13–15]. Here, CYP24A1 is linked to breast carcinoma.